Aptamer-Targeted Attenuation of IL-2 Signaling in CD8+ T Cells Enhances Antitumor Immunity.
about
Current Progress in Non-viral RNAi-Based Delivery Strategies to Lymphocytes.The γ c family of cytokines: fine-tuning signals from IL-2 and IL-21 in the regulation of the immune response.Rho GTPase effectors and NAD metabolism in cancer immune suppression.Current Advances in Aptamers for Cancer Diagnosis and Therapy.Orchestrating a Symphony on a Single Conjugate: Aptamer Targeting, Gene Silencing, and Immunomodulation to Enhance Antitumor Response.Aptamer-siRNA Chimeras: Discovery, Progress, and Future Prospects.
P2860
Aptamer-Targeted Attenuation of IL-2 Signaling in CD8+ T Cells Enhances Antitumor Immunity.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh
2017年學術文章
@zh-hant
name
Aptamer-Targeted Attenuation o ...... s Enhances Antitumor Immunity.
@en
type
label
Aptamer-Targeted Attenuation o ...... s Enhances Antitumor Immunity.
@en
prefLabel
Aptamer-Targeted Attenuation o ...... s Enhances Antitumor Immunity.
@en
P2093
P2860
P1433
P1476
Aptamer-Targeted Attenuation o ...... s Enhances Antitumor Immunity.
@en
P2093
Alexey Berezhnoy
Anugraha Rajagopalan
Brett Schrand
Eli Gilboa
Yvonne Puplampu-Dove
P2860
P356
10.1016/J.YMTHE.2016.10.021
P577
2017-01-04T00:00:00Z